The Fareva Pau laboratory, located in Idron in the Pau conurbation, was disillusioned last year when the anti-covid vaccine it was to produce for the German CureVac was abandoned for lack of effectiveness.
The Fareva Pau laboratory, located in Idron in the Pau conurbation, was disillusioned last year when the anti-covid vaccine it was to produce for the German CureVac was abandoned for lack of effectiveness.
According to our information, Fareva Pau, which employs nearly 300 people, now has an opportunity to rejoice since it has been chosen by the Taiwanese pharmaceutical group Foresee to produce its new cancer treatment, Camcevi.
Only site in the world labeled
This medicine obtained its marketing authorization in May 2021 from the very strict Food and Drug Administration (FDA), the American health authority, while an application was also filed with the European Food Safety Agency. drugs (EMA).
It is a “ready-to-use” liquid injectable for the palliative treatment of advanced prostate cancer, where current drugs must today be reconstituted by medical teams before use.
Fareva Pau, acquired from Pierre Fabre Laboratories in 2020, is currently the only site in the world labeled for the production of Camcevi, which could be marketed from the second half of 2022.
Unions unaware
On the Idron site, where the forty jobs planned for the anti-covid vaccine will not see the light of day, the information had not yet been communicated to the unions this Wednesday, January 19. “We are not aware,” says the representative of the CGT, Mathieu Van Delf.
The Fareva laboratory had started work in early 2021 on its Idron site, near Pau, for the production of a vaccine against Covid-19 which will ultimately be abandoned.
Anna Paul / “South West”
Express expansion work had begun in early 2021 on a secondary site of the laboratory, still in Idron, where a new 1,000 m² building had grown in a few weeks to accommodate the potential production of 20 million vials of vaccine per year. “It is useless, it is empty, deplores the union representative. There are 80 freezers sleeping, for nothing. »
Asked, the management of Fareva, a group specializing in the manufacture and packaging of drugs, had not yet answered us this January 19 in the middle of the afternoon.